A polymorphism in the macrophage migration inhibitory factor promoter is associated with bronchopulmonary dysplasia

Pediatric Research

Volumn 69, Issue 2, 2011, Pages 142-147

  Prencipe, Giusi ^a   Auriti, Cinzia ^a   Inglese, Rita ^b   Devito, Rita ^c   Ronchetti, Maria Paola ^a   Seganti, Giulio ^a   Ravà, Lucilla ^d   Orzalesi, Marcello ^a   De Benedetti, Fabrizio ^e  

^a Department of Neonatology ^*  (Italy)

^b Clinical Chemistry Laboratory   (Italy)

^c Division of Pathology   (Italy)

^d Epidemiology Unit   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN TISSUE; INCIDENCE; INFANT; LUNG DYSPLASIA; LUNG PARENCHYMA; MALE; PREMATURITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INFANT, PREMATURE; INTRAMOLECULAR OXIDOREDUCTASES; LOGISTIC MODELS; LUNG; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 79951628207     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3182042496     Document Type: Article

References (37)

1. Bokodi G, Treszl A, Kovacs L, Tulassay T, Vasarhelyi B 2007 Dysplasia: a review. Pediatr Pulmonol 42:952-961 (Pubitemid 47549803)
2. Greenough A 2008 Long-term pulmonary outcome in the preterm infant. Neonatology 93:324-327 (Pubitemid 351799117)
3. Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM 2006 Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol 30:171-178 (Pubitemid 44062674)
4. Ryan RM, Ahmed Q, Lakshminrusimha S 2008 Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol 34:174-190
5. Bry K, Lappalainen U, Hallman M 1997 Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 99:2992-2999 (Pubitemid 27278676)
6. Shimoya K, Taniguchi T, Matsuzaki N, Moriyama A, Murata Y, Kitajima H, Fujimura M, Nakayama M 2000 Chorioamnionitis decreased incidence of respiratory distress syndrome by elevating fetal interleukin-6 serum concentration. Hum Reprod 15:2234-2240
7. Kramer BW 2008 Antenatal inflammation and lung injury: prenatal origin of neonatal disease. J Perinatol 28: S21-S27 (Pubitemid 351622248)
8. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR 2006 Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117:1901-1906 (Pubitemid 46071232)
9. Bhandari V, Gruen JR 2006 The genetics of bronchopulmonary dysplasia. Semin Perinatol 30:185-191 (Pubitemid 44062676)
10. Hadchouel A, Decobert F, Franco-Montoya ML, Halphen I, Jarreau PH, Boucherat O, Martin E, Benachi A, Amselem S, Bourbon J, Danan C, Delacourt C 2008 Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS ONE 3: e3188
11. Hallman M, Marttila R, Pertile R, Ojaniemi M, Haataja R 2007 Genes and environment in common neonatal lung disease. Neonatology 91:298-302 (Pubitemid 46934215)
12. Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Legutko M, Pietrzyk JJ 2008 Genetic risk factors of bronchopulmonary dysplasia. Pediatr Res 64:682-688
13. Manar MH, Brown MR, Gauthier TW, Brown la 2004 Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 24:30-35 (Pubitemid 38159800)
14. Rova M, Haataja R, Marttila R, Ollikainen V, Tammela O, Hallman M 2004 Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 13:1095-1104 (Pubitemid 38786992)
15. Strassberg SS, Cristea IA, Qian D, Parton la 2007 Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia. Pediatr Pulmonol 42:29-36 (Pubitemid 46080150)
16. Calandra T, Roger T 2003 Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791-800 (Pubitemid 37328657)
17. Ayoub S, Hickey MJ, Morand EF 2008 Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract Rheumatol 4:98-105 (Pubitemid 351217659)
18. Renner P, Roger T, Calandra T 2005 Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 41: S513-S519 (Pubitemid 41598313)
19. Kim HR, Park MK, Cho ML, Yoon CH, Lee SH, Park SH, Leng L, Bucala R, Kang I, Choe J, Kim HY 2007 Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol 34:927-936 (Pubitemid 46774834)
20. Xu X, Wang B, Ye C, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S 2008 Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett 261:147-157 (Pubitemid 351253721)
21. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, Bruce LJ, Bucala R 1997 Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3:320-323 (Pubitemid 27112930)
22. Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY 2003 Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol 199:496-508 (Pubitemid 36411227)
23. Kevill KA, Bhandari V, Kettunen M, Leng L, Fan J, Mizue Y, Dzuira JD, Reyes-Mugica M, McDonald CL, Baugh JA, O'Connor CL, Aghai ZH, Donnelly SC, Bazzy-Asaad A, Bucala RJ 2008 A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome. J Immunol 180:601-608
24. Marsh LM, Cakarova L, Kwapiszewska G, von Wulffen W, Herold S, Seeger W, Lohmeyer J 2009 Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. Am J Physiol Lung Cell Mol Physiol 296: L442-L452
25. Welford SM, Bedogni B, Gradin K, Poellinger L, Broome Powell M, Giaccia AJ 2006 HIF1alpha delays premature senescence through the activation of MIF. Genes Dev 20:3366-3371 (Pubitemid 44969155)
26. Baugh JA, Gantier M, Li L, Byrne A, Buckley A, Donnelly SC 2006 Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun 347:895-903 (Pubitemid 44118203)
27. Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, Thomson W, Ray D 2002 Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 46:2402-2409
28. De Benedetti F, Meazza C, Vivarelli M, Rossi F, Pistorio A, Lamb R, Lunt M, Thomson W, Ravelli A, Donn R, Martini A 2003 Functional and prognostic relevance of the-173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 48:1398-1407 (Pubitemid 36554539)
29. Vivarelli M, D'Urbano LE, Insalaco A, Lunt M, Jury F, Tozzi AE, Ravelli A, Martini A, Donn R, De Benedetti F 2007 Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids. Clin Exp Rheumatol 25:775-781 (Pubitemid 350284856)
30. Meazza C, Travaglino P, Pignatti P, Magni-Manzoni S, Ravelli A, Martini A, De Benedetti F 2002 Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:232-237 (Pubitemid 34121669)
31. *C allele with childhood nephrotic syndrome. Pediatr Nephrol 23:743-748
32. Matoba N, Yu Y, Mestan K, Pearson C, Ortiz K, Porta N, Thorsen P, Skogstrand K, Hougaard DM, Zuckerman B, Wang X 2009 Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics 123:1320-1328
33. Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione E, Paulesu L 2002 Macrophage migration inhibitory factor in human pregnancy and labor. Am J Reprod Immunol 48:404-409 (Pubitemid 35469292)
34. Roger T, David J, Glauser MP, Calandra T 2001 MIF regulates innate immune responses through modulation of toll-like receptor 4. Nature 414:920-924 (Pubitemid 34024744)
35. Oda S, Oda T, Nishi K, Takabuchi S, Wakamatsu T, Tanaka T, Adachi T, Fukuda K, Semenza GL, Hirota K 2008 Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE 3: e2215
36. Rajatapiti P, van der Horst IW, de Rooij JD, Tran MG, Maxwell PH, Tibboel D, Rottier R, de Krijger RR 2008 Expression of hypoxia-inducible factors in normal human lung development. Pediatr Dev Pathol 11:193-199
37. Zhong XB, Leng L, Beitin A, Chen R, McDonald C, Hsiao B, Jenison RD, Kang I, Park SH, Lee A, Gregersen P, Thuma P, Bray-Ward P, Ward DC, Bucala R 2005 Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res 33: e121